Literature DB >> 17437

The actions of amphetamine on neurotransmitters: a brief review.

K E Moore.   

Abstract

The central stimulant actions of d-amphetamine are not altered in animals in which brain stores of catecholamines have been depleted with reserpine, but they are blocked by alpha-methyltyrosine, which inhibits catecholamine synthesis. The results of a variety of experiments suggest that the central actions of amphetamine result primarily from the ability of the drug to facilitate the release of newly synthesized dopamine from nerve terminals in the forebrain. The results of experiments in animals in which dopaminergic nerve terminals in various brain regions have been selectively destroyed by intracranial microinjection of 6-hydroxydopamine reveal that the locomotor stimulant actions of relatively low doses of amphetamine are dependent upon mesolimbic dopaminergic neurons, whereas the stereotyped behaviors induced by relatively larger doses of amphetamine are dependent upon nigrostriatal dopaminergic neurons. The central actions of amphetamine appear to be the primary result of interactions with dopamine neurons, but secondarily the drug also alters the dynamics of other putative neurotransmitters (e.g. acetylcholine, 5-hydroxytryptamine) in the brain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17437

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  28 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

2.  Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation during the amphetamine-induced release of endogenous dopamine in vitro.

Authors:  A J Azzaro; J Liccione; J Lucci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

3.  The effects of (+)-amphetamine and apomorphine on responding for a conditioned reinforcer.

Authors:  E J Mazurski; R J Beninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine.

Authors:  B A Bailey; S R Philips; A A Boulton
Journal:  Neurochem Res       Date:  1987-02       Impact factor: 3.996

5.  The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?

Authors:  Jason Yanofski
Journal:  Innov Clin Neurosci       Date:  2011-01

6.  Effects of acute administration of d-amphetamine and haloperidol on procedural learning in man.

Authors:  V Kumari; P J Corr; O F Mulligan; P A Cotter; S A Checkley; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

Review 7.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

8.  Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.

Authors:  R Niddam; S Arbilla; B Scatton; T Dennis; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

9.  Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.

Authors:  G P Reynolds; P Riederer; M Sandler; K Jellinger; D Seemann
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

10.  Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.

Authors:  M K Menon; C A Vivonia; V G Haddox
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.